Acute flaccid paralysis in children is a medical emergency that can progress to respiratory failure within hours or days, ...

Guillain-Barré syndrome (GBS) is an acute paralysing disease caused by inflammation of the peripheral nerves, which corticosteroids would be expected to benefit. To examine the ability of ...

And the shadow from that cloud is why I just can't justify buying Johnson & Johnson today. Why Johnson & Johnson is a great company When I look for stocks, I generally start with the dividend.

We describe a patient with Stevens-Johnson syndrome (erythema multiforme major) associated with an increase in glipizide dosage administration. Glipizide is a second-generation sulfonylurea ...

On June 19, Johnson & Johnson (NYSE:JNJ) announced the launch of two new plating systems in the United States under its VOLT platform, called Distal Radius and Proximal Humerus 3.5 Plating Systems.

To elucidate the features of patients with Guillain-Barré syndrome who show markedly rapid clinical recovery, clinical, serological, and electrophysiological data of 80 consecutive patients were ...

Johnson & Johnson offers stability with 62 years of dividend growth and a 3.44% yield. Click for why JNJ is undervalued and poised for potential 65% upside.

In the past decade, the world confronted several pandemics of emerging infectious diseases including Zika virus and most recently Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). One of ...